Author: editor

Oral Injection alternative for Acromegaly

Adults who need medical maintenance treatment of the growth hormone disorder acromegaly respond well to an investigational oral form of the drug octreotide, investigators of the Chiasma OPTIMAL study reported. Results of the phase 3 randomized controlled clinical trial were accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting, and will be published […]

HRT for post menopausal women provides lasting fitness, stamina & endurance

Menopause leaves some women unaffected, but the majority of females who experience it suffer from severe symptoms which they long to get rid of. Eventually, women tend to become interested in considering the advantages and disadvantages of hormone replacement therapy (HRT). This course of treatment has been chosen by many women to control menopause symptoms. […]

HGH supplements for anti-aging: Natural Elements in HRT

HGH anti aging supplements have found their way into most health stores and even online shops that sell fitness products. Most people who have tried these products cannot stop raving about their fabulous and conspicuous effect on their skin tone, energy level and muscles. Here is a look at what HGH is and how it […]

HGH injections therapy for Osteoporosis Treatment

For years after it was administered, growth hormone continued to reduce the risk of fractures and helped maintain bone density in postmenopausal women who had osteoporosis, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Osteoporosis is a progressive condition that causes the bones to become weak and […]

HGH for Idiopathic Short Stature

INTRODUCTION Treatment of children and adolescents with growth hormone for idiopathic short stature (ISS) is controversial for two reasons. First, the response to growth hormone is highly variable, probably because of the heterogeneous endocrinologic profile in children with ISS, and those children who respond to growth hormone treatment may have only modest increases in linear […]

Fda Transitioned Insulin To Biological Products

In this final guidance document, FDA provides Sponsors with answers to commonly asked questions regarding the BPCIA. The move is expected to have no impact on the distribution of insulin and other products affected by the transition. Section 351(k) defines “biosimilarity” to mean that the biological product is highly similar to the reference product notwithstanding […]

Evolving Latest Treatments For Growth Hormone Deficiency In Children

Significant progress has been made in the diagnosis and management of short stature since the introduction of growth hormone therapy half a century ago. Growth hormone has been approved for a range of conditions resulting in short stature beyond growth hormone deficiency, including chronic kidney dysfunction and Turner syndrome. In addition to biological causes of […]

Somapacitan Novo Nordisk : Long acting Human growth hormone injection

Novo Nordisk’s somapacitan is a long-acting human growth hormone derivative being developed to treat growth hormone deficiency. Credit: Novo Nordisk A/S. demonstrated safety, efficacy and tolerability comparable to that of once-daily Norditropin (somatropin) after one year. One of areas of focus among biopharmaceutical companies currently is having a treatment for growth hormone deficiency that reduces […]

Scroll to top